whats scary to me is how far out the Craigs analysis goes without any significant increase in yield or reduction in multiple.
in three years time you'll still be getting less than 2% return and on a PE of over 40.
Printable View
whats scary to me is how far out the Craigs analysis goes without any significant increase in yield or reduction in multiple.
in three years time you'll still be getting less than 2% return and on a PE of over 40.
After analysing revenue trend data from Jan 2021 onwards ...estimated following numbers ....Jan = $ 125 M ( + 44% PCP ) Feb = $ 120 M ( + 15 ) March = $ 155 M ( + 6 ) April = $ 165 ( + 51 )
Also seeing the infections data of top 10 most vaccinated countries ....Covid is still managing to put people in hospitals ...especially UAE and Chile ( Top vaccinated)
So its too early to write off Covid effect or boost to FPH ...IMHO
Almost all analysts have been quick to downgrade it to Hold with consensus target of $ 32.50 ( Original Forbar's )
That makes it the dark horse now ...if they get a quarter like 3rd qtr of FY 21 then all will be jumping to upgrade . Think 3rd qtr ....UK and USA stocked big time !!
Longterm holders need hold ...things can change for better suddenly too ...uncertainty of Covid cuts both ways .
Underperform is the current trend surely
Aging population(s) will continue to drive some demand for their products.
Particularly in America where people are living longer but certaintely not healthier.
Can't see Covid going anywhere any time soon, the majority of the world is only now starting to experience its highest cases.
Heavily vaccinated countries have a huge number of waiting patients, many believe this will be the new crisis as large numbers of ill and poorly people start going back to their GP and hospitals.
New rare diseases have been found showing up in recovered patients affecting the lungs, lots of long term issues needed assistants from respiratory devices.
Lots of countries will start to restock and store medical equipment?
I'm new to this game but look what happened with ATM and their guidance, how many times did they have to change to a downgrade, all due to uncertainty with covid, trade and shipments, sure some other factors also, maybe someone could tell me FPH may be trying to play it safe in uncertain times? It seems people believe the world has recovered or is recovering but it's still as much a disaster as it was when all of this kicked off
Have you got any references to back that? What I have seen is that the USA is quite low down in the list of life expectancy for developed countries. Perhaps it is because there is a vastly different outcome for Americans depending on wealth - with wealthier Americans living longer, healthier and with access to cutting edge healthcare.
List of countries by life expectancy
en.wikipedia.org/wiki/List_of_countries_by_life_expectancy#List_by_the_W orld_Health_Organization_(2019)
Interesting links. With advancing health treatments, the health conditions that people face has changed over time. This is an issue facing other countries in addition to the USA. Unequal access to health services has an effect too.
https://www.telegraph.co.uk/news/201...g-poor-health/
http://nzx-prod-s7fsd7f98s.s3-websit...173/347408.pdf
todays presentation extremely medically oriented despite being for investors and analysts....
of course its their specialty but not for me to read.
however they do map out their short medium and long term objectives though its all a bit unconvincing.
that 12% revenue growth projection seems a bit achievable.
I know nothing other than that management of FPH are top notch and tend to under promise and over deliver
12% growth projection is far higher than many analysts have arrived at. Analysts are projecting a drop off after covid.
https://www.marketscreener.com/quote...30/financials/
I am reasonably confident of which ones have a better understanding of the business